Novel H1N1 Flu

Lincoln Public Schools Takes Action

Related Correspondance

• Letter sent to LPS families
• Letter sent to LPS staff

Resources on the Web

• Lincoln Lancaster County Health Department Web site
• Flu.gov: CDC influenza site with multiple links and information
• This contains information specific to schools

Action Steps for Parents

• If School is Dismissed or Children are Sick and Must Stay Home
• For Parents to Protect Their Child and Family from the Flu this School Year
• For Parents of Children at High Risk for Flu Complications

Action Steps for Teachers

• For Teachers to Prevent the Spread of Flu

Flu.gov News Releases

• FDA Approves First Quadrivalent Vaccine to Prevent Seasonal Influenza
  FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration. FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.
• First U.S. Cell-based Flu Vaccine Plant Set for Dedication
  The first U.S. facility to use a faster and more flexible technology to make influenza vaccine was dedicated today, as part of an initiative that could provide vaccine supplies sooner in an influenza pandemic. The plant in Holly Springs, N.C., can create vaccine using cultured animal cells instead of the conventional process of using fertilized eggs.
• CDC Confirms Two Human Infections with Novel Influenza Viruses
  CDC has confirmed two cases of human infection with two different novel influenza A viruses in different states. Both patients have fully recovered.
• FDA Updated Communication on Use of Jet Injectors with Inactivated Influenza Vaccines
  The Food and Drug Administration (FDA) is recommending that health care professionals use a sterile needle and syringe to administer inactivated influenza vaccines.
• CDC Issues Initial 2011-2012 Seasonal “FluView” Report: Current Activity is Low; Outlook for Vaccine is Good
  The Centers for Disease Control and Prevention released the initial “FluView” report for the U.S. 2011–2012 flu season with the message that flu activity is currently low, making this the perfect time to get vaccinated. There should be lots of vaccine available, because the supply is projected to set a U.S. record.
• Priming with DNA vaccine makes avian flu vaccine work better
  The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say. Their report describes results from two clinical studies conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
• FDA Clears First Single Use Face Mask for Children
  The U.S. Food and Drug Administration has cleared the Kimberly-Clark Pediatric/Child Face Mask, designed to be worn in hospitals and health care facilities to help reduce the spread of airborne respiratory tract bacteria, viruses, and other pathogens.
• NIH Scientists Find Earliest Known Evidence of 1918 Influenza Pandemic
  Examination of lung tissue and other autopsy material from 68 American soldiers who died of respiratory infections in 1918 has revealed that the influenza virus that eventually killed 50 million people worldwide was circulating in the United States at least four months before the 1918 influenza reached pandemic levels that fall.
• CDC Reports Details Influenza Prevention and Treatment for Children and Teens
  Although children and teenagers rarely die from flu–related causes, many of the deaths could have been prevented if the children had been vaccinated against the flu, according to a report by the Centers for Disease Control and Prevention.
• FDA Approves Vaccines for the 2011-2012 Influenza Season
  The U.S. Food and Drug Administration announced today that it has approved the 2011-2012 influenza vaccine formulation for all six manufacturers licensed to produce and distribute influenza vaccine for the United States.
• WHO Landmark Global Agreement on Flu Virus Sharing Improves Global Preparedness for Influenza Pandemics
  After a week of negotiations continued through Friday night and into Saturday morning, an open-ended working-group meeting of Member States successfully agreed upon a framework to ensure that in a pandemic, influenza virus samples will be shared with partners who need the information to take steps to protect public health.
• U.S. Biomedical Advanced Research and Development Authority (BARDA)Funds Advanced Development of New Influenza Antiviral
  A contract has been awarded to develop a long-acting single-dose antiviral drug for use in the United States, the U.S. Biomedical Advanced Research and Development Authority (BARDA) announced today.
• New Consumer-Focused Immunization Website, www.vaccines.gov
  The U.S. Department of Health and Human Services today unveiled an innovative new website to help parents and other consumers learn about the most effective way to protect themselves and their children from infectious diseases and learn about immunization.
• Guidance for the Prevention and Control of Influenza in the Peri- and Postpartum Settings
  Guidance for the Prevention and Control of Influenza in the Peri- and Postpartum Settings
• Research Shows Single Change in H1N1 Virus Makes the Virus Bind More Easily to Human Cells and Transmits the Virus More Efficiently in Ferrets
  The 2009 H1N1 influenza A virus continues to circulate among the human population as the predominant H1N1 subtype.
• Pandemic Influenza Evaluation and Capacity Review Tools
  Flu surveillance, laboratory testing and inventory tools for use by Centers for Disease Control and Prevention (CDC) international partners and collaborating countries.
• HHS and Walgreens Announce New Effort Aimed at Addressing Health Disparities in Flu Vaccination
  U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that Walgreens has agreed to donate $10 million in vouchers for free flu shots to 350,000 eligible uninsured and underserved people in 15 markets across the country.
• H1N1 Vaccine Safe and Induces Robust Immune Response in People with Asthma
  2009 Results of NIH-supported study now available
• Presidential Proclamation--National Influenza Vaccination Week
  Last year, as the world prepared for a pandemic of the 2009 H1N1 influenza virus, we were reminded of the severity and unpredictability of this serious disease.
• A Flu Vaccine that Lasts: NIH Scientists Consider Prospects for a Universal Influenza Vaccine
  The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain.
• National Influenza Vaccination Week to be held December 5-11, 2010
  The Centers for Disease Control and Prevention (CDC) has set aside the week of December 5-11, 2010 to observe this season's National Influenza Vaccination Week. The week-long emphasis on flu vaccination was established to highlight the importance of continuing influenza vaccination...
• Seasonal Flu and 2009 H1N1 Flu Vaccination Coverage Among Pregnant Women, 2009--10 Flu Season
  Because pregnant women are at increased risk for severe disease associated with influenza infection, the American College of Obstetricians and Gynecologists and the Advisory Committee on Immunization Practices have recommended seasonal influenza vaccination for women while pregnant, regardless of trimester...
• NIH Experts Describe Influenza Vaccines of the Future
  Efforts to grow the vaccine virus in cells rather than eggs are currently under way and there is consideration of the addition to influenza vaccine of immune-stimulating adjuvants to be used in certain groups of individuals.
• Interim Guidance on the Use of Influenza Antiviral Agents During the 2010-2011 Influenza Season
  The following guidance on the use of influenza antiviral drugs for the prevention and control of influenza during the 2010-2011 season has been submitted to the Morbidity and Mortality Weekly Report (MMWR) and will appear in that publication at a later date.
• NIH Scientists Explore 1510 Influenza Pandemic and Lessons Learned
  A new commentary by researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, explores the 1510 pandemic and what we have learned since then about preventing, controlling and treating influenza.
• New Study Re-examines Bacterial Vaccine Studies Conducted During 1918 Influenza Pandemic
  Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be important in modern pandemics as well.
• 2010-2011 Seasonal Influenza (Flu) Vaccine Safety
  Questions and answers on the safety of the 2010-2011 flu vaccine, including possible mild reactions.
• Seasonal Flu Information for Businesses and Employees
  Toolkit and other materials for businesses, employers, and their employees to learn ways to prevent the flu.
• Final Estimates for 2009–10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage – U.S., August, 2009 through May, 2010
  Because the novel influenza A (H1N1) virus [2009 influenza A (H1N1)] was identified in April 2009, two separate influenza vaccines were distributed in the United States in 2009–2010: a seasonal vaccine and an influenza A (H1N1) 2009 monovalent vaccine (2009 H1N1 vaccine).
• Influenza Activity - United States and Worldwide, June 13--September 25, 2010
  Answers to common questions regarding influenza vaccine strain selection, including information on the virus strains recommended for use in the Northern and Southern Hemisphere influenza vaccines.
• Influenza Vaccination Coverage among Children Aged 6-23 Months - U.S., 2008-09 Influenza Season
  Answers to common questions regarding influenza vaccine strain selection, including information on the virus strains recommended for use in the Northern and Southern Hemisphere influenza vaccines.
• Q and A: Vaccine Selection for the 2010-2011 Influenza Season
  Answers to common questions regarding influenza vaccine strain selection, including information on the virus strains recommended for use in the Northern and Southern Hemisphere influenza vaccines.
• BARDA Funds Development of Next-Generation Portable Ventilators
  The contract will help fill the need for domestically manufactured, low-cost, user-friendly, and flexible next-generation ventilators.
• Health Requirements and Recommendations for Travel to Saudi Arabia During the 2010 Hajj: Information for U.S. Travelers
  Saudi Arabia updates its health and immunization requirements for travelers
• NIH study models H1N1 flu spread
  As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.
• Cómo limpiar y desinfectar las escuelas para ayudar a disminuir la propagación de la influenza
  La limpieza y la desinfección son parte de una amplia estrategia para prevenir las enfermedades infecciosas en las escuelas. Para ayudar a disminuir la propagación de la influenza (gripe), la primera l�ínea de defensa es la vacunación. Otras medidas comprenden cubrirse la nariz y la boca al toser o estornudar, lavarse las manos y mantener a las personas enfermas alejadas de las sanas.
• How to Clean and Disinfect Schools to Help Slow the Spread of Flu
  Cleaning and disinfecting are part of a broad approach to preventing infectious diseases in schools. To help slow the spread of influenza (flu), the first line of defense is getting vaccinated. Other measures include covering coughs and sneezes, washing hands, and keeping sick people away from others. Below are tips on how to slow the spread of flu specifically through cleaning and disinfecting.
• Get information about high-risk groups, flu symptoms and emergency warning signs, and get CDC recommendations.
  This document from the Centers for Disease Control and Prevention (CDC), an agency of the U.S. Department of Health and Human Services, provides guidance to help reduce the spread of seasonal influenza (flu) among students and staff in K-12 schools during the 2010-2011 school year.
• Influenza Vaccination Information for Health Care Workers
  This document provides lists of facts and recommendations for health care workers concerning the flu and vaccinations.
• Estimating Seasonal Influenza-Associated Deaths in the U.S: CDC Study Confirms Variability of Flu
  Estimating Seasonal Influenza-Associated Deaths in the United States: CDC Study Confirms Variability of Flu
• Review Calls for New Federal Approach to Medical Countermeasures
  HHS Secretary releases review and recommendations driven by pandemic flu experience
• WHO Director-General Statement
  The world is no longer in phase 6 of influenza pandemic alert. We are now moving into the post-pandemic period. The new H1N1 virus has largely run its course.
• WHO Recommendations for the Post-pandemic Period
  The world is now in the post-pandemic period. Based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus for some years to come.
• Questions and Answers: CSL Seasonal Influenza Vaccine Safety in the U.S.
  CSL Seasonal Influenza Vaccine Safety in the United States
• Recommended Flu Vaccines for Different Age Groups
  Recommended Flu Vaccines for Different Age Groups - U.S., 2010-11 Season
• WHO Updates International H1N1 Flu Situation
  As of 1 August 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18449 deaths.
• FDA Approves Vaccines for the 2010-2011 Influenza Season
  The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States.
• Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
  This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza.
• NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice
  For many years, researchers have been working to find a way to deliver flu vaccine - whose components are much larger than those of nicotine and hormones - using a transdermal (across the skin) patch.
• NIH Scientists Advance Universal Flu Vaccine
  A universal influenza vaccine - so-called because it could potentially provide protection from all flu strains for decades - may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
• H1N1 Influenza Public Health Emergency Determination to Expire on June 23
  H1N1 Influenza Public Health Emergency Determination to Expire on June 23
• Advance Notice for Termination of the Emergency Use Authorization (EUA) of Medical Products and Devices
  Per the FDA-issued advance notice letters listed below, the declaration of Public Health Emergency determination for 2009 H1N1 Influenza expires on June 23, 2010.
• New CDC Test to Detect Human Infections with the 2009 H1N1 Influenza Virus Authorized for Use by FDA
  A test developed by the U.S. Centers for Disease Control and Prevention to diagnose human infections with the 2009 H1N1 influenza virus (formerly known as swine flu or pandemic H1N1 flu) was authorized for use today by the U.S. Food and Drug Administration.
• WHO Updates International H1N1 Flu Situation
  As of 13 June, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18172 deaths.
• FDA Warns About Fraudulent Tamiflu
  The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as Generic Tamiflu sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.
• CDC issues 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010
  Centers for Disease Control and Prevention document that summarizes key events of the 2009 H1N1 pandemic and CDC's response activities.
• NIH-Funded Scientists Find 2009 H1N1 Pandemic Influenza Vaccine Protects Mice from 1918 Influenza Virus
  Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
• WHO Director-General Statement on Continuation of Pandemic Disease
  A global update was provided to the Committee on the pandemic situation, including a particular focus on developments in Africa and the Southern Hemisphere.
• Preliminary Results: Surveillance for Guillain-Barre Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine --- United States, 2009--2010
  Guillain-Barre syndrome (GBS) is an uncommon peripheral neuropathy causing paralysis and in severe cases respiratory failure and death.
• The World Health Organization (WHO) Recommends Vaccine Composition for the 2011-2012 Northern Hemisphere Influenza Season
  The World Health Organization (WHO) Recommends Vaccine Composition for the 2011-2012 Northern Hemisphere Influenza Season